XBiotech Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | |
| – | 16.6% | 16.6% | – | – | – | 51.0% | – | – | – | – | – | – | |
| – | -16.6% | -16.6% | – | – | – | -51.0% | – | – | – | – | – | – | |
| – | 297.9% | 375.0% | – | – | – | 1,340.1% | – | – | – | – | – | – | |
| – | 29.9% | 39.2% | – | – | – | 222.7% | – | – | – | – | – | – | |
| – | 311.2% | 414.2% | – | – | – | 1,562.9% | – | – | – | – | – | – | |
| – | -327.7% | -414.2% | – | – | – | -1,562.9% | – | – | – | – | – | – | |
| – | 125.6% | 125.6% | – | – | – | 10.1% | – | – | – | – | – | – | |
| – | -180.7% | -380.8% | – | – | – | -1,252.0% | – | – | – | – | – | – | |
| – | -3.8% | 1.0% | – | – | – | 3.3% | – | – | – | – | – | – | |
| – | -176.9% | -381.8% | – | – | – | -1,255.4% | – | – | – | – | – | – | |
| – | -164.1% | -356.7% | – | – | – | -1,190.9% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.